GENE ONLINE|News &
Opinion
Blog

Immunotherapy
Trials & Approvals Yescarta
Kite’s Yescarta – The First CAR-T Cell Therapy Approved for B cell Lymphoma
2022-04-06
R&D Immunotherapy
Roche’s Phase III Trial of ES-SCLC Immunotherapy Fails to Extend Progression-Free Survival
2022-04-05
COVID-19 Vaccine
Pfizer: Pneumonia Shot Can Be Given with COVID-19 Vaccine in Older Adults
2022-01-16
Special Breast Cancer
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Licensing Immuno-oncologyNovartis
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
IPO BeiGene
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Special Cancer
Cancer Cells Build Nano-Highways to Hijack Mitochondria from Immune Cells
2021-11-25
Special Cancer
New Research on Neoantigens and Tumor-targeting T-cells Marks Paradigm Shift in Countering Solid Tumors
2021-11-19
Trials & Approvals Keytruda
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
Funding Immunotherapy
Boston-Based Cancer Immunotherapy Startup Secures $45 Million in Series B
2021-11-15
Trials & Approvals
AstraZeneca’s Imfinzi, Tremelimumab Combo Significantly Improves Overall Survival in Phase 3 Trials
2021-10-18
Licensing Cancer Immunotherapy
Xencor and Janssen Join Forces Against B-cell Lymphoma in a New Billion-Dollar Deal
2021-10-05
Special Cancer Immunotherapy
Bispecific Antibodies or CAR T-Cells: Which One of These Cancer Immunotherapies Would Prevail?
2021-09-29
Licensing cGVHD
Syndax, Incyte Sign $602 Million Collab to Advance Monoclonal Antibody
2021-09-29
Special
ESMO21: Latest Clinical Studies Answer Central Questions in the Treatment of Leading Cancers
2021-09-22
1 2 3 4 … 7
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top